Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3^Δ25bp variant

Area of Science:

• Genetics
• Cardiology
• Molecular Biology

Background:

• Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
• Mutations in the myosin-binding protein C gene (MYBPC3) cause approximately 40% of genetically defined HCM cases.
• A specific 25-base pair deletion in MYBPC3 intron 32 (MYBPC3^Δ25bp) is prevalent in South Asians and linked to autosomal dominant cardiomyopathy.

Purpose of the Study:

• To review current research on the molecular pathophysiology of HCM in South Asians with the MYBPC3^Δ25bp variant.
• To highlight the latest techniques used to investigate MYBPC3^Δ25bp pathogenesis.
• To establish a foundation for developing novel diagnostic and therapeutic strategies.

Main Methods:

• Review of existing scientific literature and research findings.
• Analysis of molecular mechanisms underlying HCM in the context of the MYBPC3^Δ25bp variant.
• Exploration of genetic and environmental factors influencing disease presentation.

Main Results:

• The MYBPC3^Δ25bp variant is a significant cause of HCM in South Asian populations.
• The precise molecular mechanisms leading to left ventricular dysfunction and heart failure require further elucidation.
• Secondary risk factors, additional genetic mutations, and lifestyle choices can modify the HCM phenotype in carriers.

Conclusions:

• Understanding the molecular pathophysiology of MYBPC3^Δ25bp-associated HCM is crucial for targeted interventions.
• Advanced research techniques are essential for unraveling the complex disease mechanisms.
• Developing new diagnostic tools and therapeutic approaches is a key future direction for managing HCM in this population.